Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates
Blake J. Rust, Leslie S. Kean, Lucrezia Colonna, et al.
Blood (2020) Vol. 136, Iss. 15, pp. 1722-1734
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks, Nancie M. Archin, Paula M. Cannon, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2085-2098
Open Access | Times Cited: 243
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
Thomas S. Uldrick, Scott V. Adams, Rémi Fromentin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 629
Open Access | Times Cited: 73
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection
Wenli Mu, Vaibhavi Patankar, Scott G. Kitchen, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 219-219
Open Access | Times Cited: 13
Broadly neutralizing antibody–derived CAR T cells reduce viral reservoir in individuals infected with HIV-1
Bingfeng Liu, Wanying Zhang, Baijin Xia, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 19
Open Access | Times Cited: 60
Applying a clinical lens to animal models of CAR-T cell therapies
Brynn B. Duncan, Cynthia E. Dunbar, Kazusa Ishii
Molecular Therapy — Methods & Clinical Development (2022) Vol. 27, pp. 17-31
Open Access | Times Cited: 40
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells
Mayra A. Carrillo, Anjie Zhen, Wenli Mu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1000-1015
Open Access | Times Cited: 9
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
Mary S. Pampusch, Hadia M. Abdelaal, Emily K. Cartwright, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1009831-e1009831
Open Access | Times Cited: 27
Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells
Yuanyuan Zhang, Tong Ge, Meijuan Huang, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 49-63
Open Access | Times Cited: 15
Anti–PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers
Karsten Eichholz, Yoshinori Fukazawa, Christopher W. Peterson, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 7
Open Access | Times Cited: 5
Engineering of CD8 + T cells with an HIV-specific synthetic notch receptor to secrete broadly therapeutic antibodies for combining antiviral humoral and cellular immune responses
Lina Meng, Hongwei Zhao, Shuang Chang, et al.
mBio (2025)
Open Access
Genome editing in large animal models
Lucy H. Maynard, Olivier Humbert, Christopher W. Peterson, et al.
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3140-3152
Open Access | Times Cited: 33
In vivo killing of primary HIV-infected cells by peripheral-injected early memory–enriched anti-HIV duoCAR T cells
Kim Anthony-Gonda, Alex Ray, Hang Su, et al.
JCI Insight (2022) Vol. 7, Iss. 21
Open Access | Times Cited: 26
Opportunities for CAR-T Cell Immunotherapy in HIV Cure
Gerard Campos-Gonzalez, Javier Martínez‐Picado, Talía Velasco-Hernández, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 789-789
Open Access | Times Cited: 13
HIV-1 Reservoir Persistence and Decay: Implications for Cure Strategies
Edward F. Kreider, Katharine J. Bar
Current HIV/AIDS Reports (2022) Vol. 19, Iss. 3, pp. 194-206
Open Access | Times Cited: 19
Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque
Gavin I. Ellis, Kimberly E. Coker, Delaine W. Winn, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 5, pp. 100614-100614
Open Access | Times Cited: 18
Application of CAR‐T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment
Nasim Adabi, Safoora Pordel, Mohammad Ali Rezaee, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 5
Closed Access | Times Cited: 11
Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 9
CAR T Cell Immunotherapy Beyond Haematological Malignancy
Cedric Hupperetz, Sangjoon Lah, Hyojin Kim, et al.
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Strategies for enhancing CAR T cell expansion and persistence in HIV infection
Frederik Holm Rothemejer, Nanna Pi Lauritsen, Ole S. Søgaard, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine
Min Guan, Laura Lim, Leo Holguin, et al.
Molecular Therapy — Methods & Clinical Development (2022) Vol. 25, pp. 344-359
Open Access | Times Cited: 11
Interests of the Non-Human Primate Models for HIV Cure Research
Gauthier Terrade, Nicolas Huot, Caroline Petitdemange, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 958-958
Open Access | Times Cited: 14
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission
Hang Su, April Mueller, Harris Goldstein
Current Opinion in HIV and AIDS (2024) Vol. 19, Iss. 4, pp. 169-178
Closed Access | Times Cited: 1
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques
Françoise Haeseleer, Yoshinori Fukazawa, Haesun Park, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 22, pp. 304-319
Open Access | Times Cited: 7
Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells
Brianna C. Davey, Mary S. Pampusch, Emily K. Cartwright, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top